Catecholaminergic and/or cyclic AMP(cAMP)systems have been demonstrated to be involved in the development of drug dependence.We investigated the involvement of both systems in psychological dependence on phencyclidine(PCP)by using tyrosine hydroxylase(TH)heterozygous(TH
+/-)and cAMP response element binding protein(CREB)binding protein(CBP)heterozygous(CBP
+/-)mice.PCP(8 mg/kg)induced place preference in wild−type mice pretreated with PCP(10 mg/kg once a day for 28 days).In these mice, the level of cAMP in the striatum, but not in the thalamus, was increased one day after the last injection of PCP(10 mg/kg).In TH
+/- and CBP
+/- mice pretreated with PCP(10 mg/kg per day for 28 days), however, no PCP(8 mg/kg)−induced place preference was observed.The level of cAMP in the striatum was increased in CBP
+/- mice, but not TH
+/- mice.Furthermore, we have demonstrated that the place preference induced by PCP is attenuated by 6−hydroxydopamine, a dopaminergic neurotoxin, and(+)SCH−23390, a dopamine−D1 receptor antagonist, but not by DSP−4, a noradrenergic neurotoxin, and(−)sulpiride, a dopamine−D2 receptor antagonist.These findings suggest that catecholamines and CBP are involved in the development of psychological dependence on PCP and that changes in dopaminergic and/or cAMP systems induced by repeated PCP treatment play an important role in the addiction to PCP.
View full abstract